Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans
- 1 April 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 179 (1-2) , 65-73
- https://doi.org/10.1016/0014-2999(90)90402-r
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Diuretic and natriuretic responses in rats treated with enkephalinase inhibitorsEuropean Journal of Pharmacology, 1990
- Inactive of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11)European Journal of Pharmacology, 1990
- Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failureThe Lancet, 1990
- Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.Circulation Research, 1989
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Proton NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognitionJournal of Medicinal Chemistry, 1986
- The Renal Response to Acute Hypervolemia is Caused by Atrial Natriuretic PeptidesJournal of Cardiovascular Pharmacology, 1986
- Radioimmunoassay of atrial natriuretic factor: Human plasma levelsBiochemical and Biophysical Research Communications, 1985
- Immunoreactive atrial natriuretic factor (IR-ANF) in human plasmaBiochemical and Biophysical Research Communications, 1985
- The Heart and the Atrial Natriuretic Factor*Endocrine Reviews, 1985